Pages Menu
TwitterRssFacebook
ISSN (Online): 0975-8232,
ISSN (Print): 2320-5148

International Journal Of
Pharmaceutical Sciences And Research

Inclusion in Web of Science (Thomson Reuters) - ESCI
Projected Impact Factor (2017): 0.59 , CiteScore (2017): 0.27
Five-Year Projected Impact Factor: 1.83

Categories Menu

Most Cited

CITATIONS REPORT: (Source- Google Scholar)
Year2010201120122013201420152016Total
No. of Published Articles2404807606367036576254101
Citations160427713051147592752124610595
Article published in 2010 and 2011: 720, Citation in 2012 to articles Published in 2010 and 2011- 4375
Impact Factor (2012): 4375/720 = 6.07 (On the basis of citations)

Article published in 2011 and 2012: 1240, Citation in 2013 to articles Published in 2011 and 2012- 5822
Impact Factor (2013): 5822/1240 = 4.69 (On the basis of citations)

Article published in 2012 and 2013: 1396, Citation in 2014 to articles Published in 2012 and 2013- 4526
Impact Factor (2014): 4526/1396 = 3.24 (On the basis of citations)

Article published in 2013 and 2014: 1339, Citation in 2015 to articles Published in 2013 and 2014- 2402
Impact Factor (2015): 2402/1339 = 1.79 (On the basis of citations)

Article published in 2014 and 2015: 1360, Citation in 2016 to articles Published in 2014 and 2015- 1448
Impact Factor (2016): 1448/1360 = 1.06 (On the basis of citations)

Article published in 2015 and 2016: 1282, Citation in 2017 to articles Published in 2015 and 2016- 767
Impact Factor (2017): 767/1282 = 0.59 (On the basis of citations)


Five Year Impact Factor: 6220/3381 = 1.83
Total Citations: 10595
 
Title
Views
PDF
Cited
44.

FORMULATION AND DEVELOPMENT OF FLAVOXATE HYDROCHLORIDE EXTENDED RELEASE CAPSULES

Flavoxate Hydrochloride is an antispasmodic, mainly used for treating painful urination, urgency of urination and incontinence. The primary objective of the study was to formulate extended release capsules of Flavoxate hydrochloride to reduce dosing frequency and decreasing the associated side effects. The extended release capsules were formulated using extrusion spheronisation process with ethyl ...

K. Satyavathi*, M. Venu, P. Gayathri, P. Bhojaraju and L.K. Kanthal

Koringa College of Pharmacy, Department of Pharmaceutics, Korangi-533 461, Tallarevu (M), E.G. Dist., Andhra Pradesh, India

DOI: http://dx.doi.org/10.13040/IJPSR.0975-8232.5(5).1949-56

1949-1956

1818

1437

14.

SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF SOME NOVEL 1- PHENYL 1-H-PYRAZOLO[3,4-D]PYRIMIDINE DERIVATIVES

Novel 1- Phenyl 1-H-Pyrazolo[3,4-d]Pyrimidine Derivatives were synthesized from the key intermediate chloro derivative (1).The conversion of chloro derivative(1) into 1,2,4 triazoles, 1,3,4 thiadiazoles and thiazoles was accomplished with the intermediacy of the ester(2) and hydrazide (3). Moreover triazole ring was annelated to the pyrazolopyrmidine core in two step reaction involving reaction wi...

Samy M. Ibrahim, M. Abou-Kul, Moustafa K. Soltan, and Ahmed M. El-Sayed

Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt

DOI: 10.13040/IJPSR.0975-8232.6(8).3236-44

3236-44

2227

840

Page 586 of 586« First...102030...582583584585586